SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (3443)2/13/2022 2:44:04 PM
From: CuttingEdge Bio  Read Replies (2) | Respond to of 3557
 
Week 44 would have been the next dose if the study continues beyond this time period (ie, a scheduled dose 12 weeks after the dose at week 32).

4 weeks following the shot (of either dose) would be the same, as it is at all previous analogous timepoints (week 12, week 24, week 36), and you would want to know what happens at week 56 to compare the two doses, not week 48.